Mesa Laboratories Inc. Common Stock
MLABUnited States
5 filed reports · 279 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 1,005 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 923 | Mar 2026 |
Financial data
279 concepts · 1,928 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial267 concepts · 1,538 facts · Mar 2024 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations13 · Mar 2024 to Jun 2026
- Stockholders equity (US GAAP)13 · Mar 2024 to Jun 2026
- Adjustments related to tax withholding for share based compensation12 · Mar 2024 to Jun 2026
- Amortization of intangible assets12 · Mar 2024 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect12 · Mar 2024 to Jun 2026
- Comprehensive income net of tax12 · Mar 2024 to Jun 2026
- Cost of revenue (US GAAP)12 · Mar 2024 to Jun 2026
- Depreciation12 · Mar 2024 to Jun 2026
- Dividends common stock cash12 · Mar 2024 to Jun 2026
- General and administrative expense (US GAAP)12 · Mar 2024 to Jun 2026
- Gross profit (US GAAP)12 · Mar 2024 to Jun 2026
- Income tax expense benefit12 · Mar 2024 to Jun 2026
- Increase decrease in accounts payable12 · Mar 2024 to Jun 2026
- Increase decrease in accounts receivable12 · Mar 2024 to Jun 2026
- Increase decrease in accrued liabilities12 · Mar 2024 to Jun 2026
- Increase decrease in contract with customer liability12 · Mar 2024 to Jun 2026
- Increase decrease in inventories12 · Mar 2024 to Jun 2026
- Increase decrease in prepaid expense12 · Mar 2024 to Jun 2026
- Interest expense nonoperating12 · Mar 2024 to Jun 2026
- Net cash provided by used in financing activities12 · Mar 2024 to Jun 2026
- Net cash provided by used in investing activities12 · Mar 2024 to Jun 2026
- Net cash provided by used in operating activities12 · Mar 2024 to Jun 2026
- Net income loss12 · Mar 2024 to Jun 2026
- Net income loss available to common stockholders basic12 · Mar 2024 to Jun 2026
Segment9 concepts · 342 facts · Mar 2024 to Jun 2026
- Cost of goods and services sold amortization48 · Mar 2024 to Jun 2026
- Cost of goods and services sold depreciation48 · Mar 2024 to Jun 2026
- Cost of revenue (US GAAP)48 · Mar 2024 to Jun 2026
- Gross profit (US GAAP)48 · Mar 2024 to Jun 2026
- Other cost of revenues (b)48 · Mar 2024 to Jun 2026
- Revenue48 · Mar 2024 to Jun 2026
- Goodwill foreign currency translation gain loss28 · Mar 2025 to Jun 2026
- Non-cash GKE inventory step-up amortization24 · Mar 2024 to Mar 2025
- Goodwill impairment loss2 · Mar 2024
Geography1 concepts · 36 facts · Mar 2024 to Jun 2026
- Revenue36 · Mar 2024 to Jun 2026
Product2 concepts · 12 facts · Mar 2024 to Mar 2026
- Cost of revenue (US GAAP)6 · Mar 2024 to Mar 2026
- Revenue6 · Mar 2024 to Mar 2026
Segments
390 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments4 members · 342 facts
- Biopharmaceutical Development86 · Mar 2024 to Jun 2026
- Clinical Genomics86 · Mar 2024 to Jun 2026
- Calibration Solutions85 · Mar 2024 to Jun 2026
- Sterilization And Disinfection Control85 · Mar 2024 to Jun 2026
Statement geographical3 members · 36 facts
- CN12 · Mar 2024 to Jun 2026
- Other12 · Mar 2024 to Jun 2026
- US12 · Mar 2024 to Jun 2026
Product or service2 members · 12 facts
- Product6 · Mar 2024 to Mar 2026
- Service6 · Mar 2024 to Mar 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2027 Q1Aug 10, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.